- Home
- TDW vs NAMS Comparison
TDW vs NAMS Comparison
Compare TDW & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDW
- NAMS
- Stock Information
- Founded
- TDW 1956
- NAMS 2019
- Country
- TDW United States
- NAMS Netherlands
- Employees
- TDW N/A
- NAMS N/A
- Industry
- TDW Marine Transportation
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- TDW Consumer Discretionary
- NAMS Health Care
- Exchange
- TDW Nasdaq
- NAMS Nasdaq
- Market Cap
- TDW 2.4B
- NAMS 2.5B
- IPO Year
- TDW N/A
- NAMS N/A
- Fundamental
- Price
- TDW $47.96
- NAMS $22.16
- Analyst Decision
- TDW Hold
- NAMS Strong Buy
- Analyst Count
- TDW 3
- NAMS 9
- Target Price
- TDW $69.00
- NAMS $41.11
- AVG Volume (30 Days)
- TDW 949.9K
- NAMS 854.7K
- Earning Date
- TDW 08-05-2025
- NAMS 08-06-2025
- Dividend Yield
- TDW N/A
- NAMS N/A
- EPS Growth
- TDW 32.96
- NAMS N/A
- EPS
- TDW 3.34
- NAMS N/A
- Revenue
- TDW $1,358,115,000.00
- NAMS $47,140,000.00
- Revenue This Year
- TDW $0.68
- NAMS N/A
- Revenue Next Year
- TDW $6.20
- NAMS N/A
- P/E Ratio
- TDW $14.33
- NAMS N/A
- Revenue Growth
- TDW 19.34
- NAMS 586.97
- 52 Week Low
- TDW $31.17
- NAMS $14.06
- 52 Week High
- TDW $106.50
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- TDW 55.56
- NAMS 63.14
- Support Level
- TDW $45.71
- NAMS $20.53
- Resistance Level
- TDW $53.48
- NAMS $22.75
- Average True Range (ATR)
- TDW 2.00
- NAMS 1.05
- MACD
- TDW -0.33
- NAMS 0.22
- Stochastic Oscillator
- TDW 49.82
- NAMS 86.51
About TDW Tidewater Inc.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.